Evoq Therapeutics
PrivateLast Round
Grant
Aug 29, 2024
Total Funding Raised
$6.73M
Company Overview
Evoq Therapeutics operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Grant round in August 2024.
Evoq Therapeutics is a biotechnology company that is developing a pipeline of disease-specific immune modulators to treat patients afflicted with autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evoq Therapeutics Comparables
Compare Evoq Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Parvus Therapeutics Inc. | 88% | |
| Anokion | 84% | |
| Cour Pharma | 84% |
For institutional investors. Book with your work email.
Evoq Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 29, 2024 | ||||
| Grant | Oct 14, 2022 | ||||
| Convertible Debt | Oct 25, 2021 | ||||
| Grant | Nov 13, 2019 | ||||
| Seed | Nov 5, 2018 | ||||
Debt | Sep 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evoq Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest Detroit | Seed, Grant |
| Ralph C. Wilson, Jr. Foundation | Grant |
| NIH RADx | Grant |
| Ann Arbor SPARK | Grant, Convertible Debt, Debt |
| BELLE Impact Fund | Grant |
| Forbes Institute for Cancer Discovery | Grant |
| William Davidson Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 32% MoM.
- Apr 22, 2026
Grew 30% QoQ from 10 to 13 employees.
For institutional investors. Book with your work email.
Evoq Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evoq Therapeutics's valuation, stock price, and market status.
Is Evoq Therapeutics a public or private company?
Evoq Therapeutics is a private company.
What is the current stock price of Evoq Therapeutics?
Evoq Therapeutics is a private company, so its shares have no public market price. Caplight tracks Evoq Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evoq Therapeutics worth (valuation)?
Valuation information for Evoq Therapeutics is not publicly available.
Can I buy Evoq Therapeutics stock?
Evoq Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evoq Therapeutics's last funding round?
Evoq Therapeutics's most recent funding round was Grant on August 29, 2024.
Who are the main investors in Evoq Therapeutics?
Key investors in Evoq Therapeutics include Invest Detroit, NIH RADx, Ann Arbor SPARK.
Will Evoq Therapeutics IPO soon?
No public IPO plans have been announced for Evoq Therapeutics.
How can I track Evoq Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Evoq Therapeutics's shares on secondary markets.